Parkinson's Disease Research Advances
UT Southwestern has a national reputation for providing outstanding care, along with access to the latest research, including clinical trials.
Our research programs investigate the genetic and other contributing factors that cause movement disorders. Among the most important of these investigations is a long-term National Institutes of Health (NIH)-funded trial aiming to discover a biomarker for Parkinson’s disease progression.
Clinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease. When you or a family member take part in a Parkinson’s clinical trial, you add to the knowledge about the disease and help improve treatment for others in the future.
Richard Dewey, M.D., is leading a major NIH-funded study that’s attempting to identify biomarkers for Parkinson’s disease – substances in the blood or spinal fluid that could be used to diagnose the disease and track its progression. If we discover a biomarker, we hope to better understand the cause of Parkinson’s disease and accelerate the discovery of new therapies or perhaps even a cure.
Request an Appointment
To schedule an appointment with a Parkinson’s disease specialist at UT Southwestern’s facilities in Dallas, or to learn more about our services, request an appointment or call 214-645-8300.